Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.

Molecules (Basel, Switzerland) - 5 Mar 2021

Telkoparan-Akillilar Pelin, Panieri Emiliano, Cevik Dilek, Suzen Sibel, Saso Luciano

Abstract excerpt

Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associated protein 1 (KEAP1) are main players of the cellular defense mechanisms against internal and external cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenesis, Genetic
Share to Genes, Tumor Suppressor
Share to Kelch-Like ECH-Associated Protein 1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to NF-E2-Related Factor 2

Share to Oxidative Stress

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 33808001
DOI: 10.3390/molecules26051417
PMCID: PMC7961421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.PMID 33808001Read ↗

Nrf2: bane or blessing in cancer?Semantic proximity Read ↗

Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.Semantic proximity Read ↗

The Keap1–Nrf2 system in cancers: stress response and anabolic metabolismSemantic proximity Read ↗

The Dual Roles of NRF2 in Cancer.Semantic proximity Read ↗

KEAP1/NRF2 (NFE2L2) mutations in NSCLC - Fuel for a superresistant phenotype?Semantic proximity Read ↗

Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.Semantic proximity Read ↗

NRF-mediated autophagy and UPR: Exploring new avenues to overcome cancer chemo-resistanceSemantic proximity Read ↗

NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of TumourigenesisSemantic proximity Read ↗

[Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].Semantic proximity Read ↗

Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer TreatmentSemantic proximity Read ↗

The tumor suppressive role of KEAP1: Underlying mechanisms and therapeutic implications.Semantic proximity Read ↗

Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.